This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Neurology
Neurology
Industry slams UK’s NICE
Alzheimer’s drug decision challenged
Antidopaminergic therapy monitoring in patients with Parkinson’s disease
Miraxion fails to meet endpoints in phase III trials for Huntington’s disease
EC approves sodium oxybate treating narcolepsy with cataplexy in adults
Advances in multiple sclerosis treatment
Advances in the treatment of Alzheimer’s disease
Treatment of cataplexy in narcolepsy
Current options for the treatment of cataplexy
Immunomodulatory drugs for multiple sclerosis
Drug treatment of epilepsy in the elderly
Neurological agent adverse reactions
« Previous
1
…
31
32
33
34
35
36
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: